EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bivalent Vaccine against Streptococcus agalactiae and Aeromonas hydrophila in Nile Tilapia (Oreochromis niloticus): A Laboratory-Phase and Large-Scale Study

Açucena Veleh Rivas iD, Angelo Gabriel Vidal Dos Santos, Adrieli Barboza de Souza, Gilson Bueno Junior, Gabriela Fernandes de Souza, Estevam Martins de Souza, Louisiane de Carvalho Nunes, Kelvinson Fernandes Viana iD

Animals · 26.10.2023 · 13 (21) · 3338

DOI: 10.3390/ani13213338 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Animals, online erschienen am 26.10.2023. Verfasst von Açucena Veleh Rivas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine Development Technology Laboratory, Latin American Institute of Life and Nature Sciences, Federal University of Latin American Integration, Fo…. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação Araucária, Federal University of Latin American Integration and Fundação Araucária.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One of the main factors limiting tilapia’s production is the occurrence of infections caused by Aeromonas and Streptococcus species. This work intended to evaluate a bivalent vaccine against A. hydrophila and S. agalactiae by intraperitoneal (i.p) administration in Nile tilapia (Oreochromis niloticus) in Brazil. The study was carried out in two phases: one in the laboratory, on a small scale, and from the results obtained, the study was expanded to a large scale in a production system in cages. The vaccine proved to be safe and effective in laboratory tests, with a vaccine efficacy (VE) of 93.66%. However, in large-scale tests with 12,000 tilapias, the VE was 59.14%, with a better food conversion ratio (1.54 kg) in the vaccinated group compared to the control group (1.27 kg). These results corroborate the efficiency of this tested vaccine; however, they indicate the need for field tests to attest to real protection.

Schlagwörter

Stichwörter der Autor:innen

aquaculturefishimmunizationtilapiculturevaccine

Autor:innen und Institutionen

  • Vaccine Development Technology Laboratory, Latin American Institute of Life and Nature Sciences, Federal University of Latin American Integration, Foz do Iguaçu 85870-650, Brazil.
  • Alquimia Pescados, Foz do Iguaçu 85870-180, Brazil.
  • Department of Veterinary Medicine, Agricultural Sciences and Engineer Center, Federal University of Espírito Santo, Alegre 29500-000, Brazil.

ORCID-Profile: Açucena Veleh Rivas, Kelvinson Fernandes Viana

Förderung

  • Fundação Araucária
  • Federal University of Latin American Integration and Fundação Araucária

Zitieren

APA

Rivas, A. V., Dos Santos, A. G. V., de Souza, A. B., Bueno Junior, G., de Souza, G. F., de Souza, E. M., de Carvalho Nunes, L., & Viana, K. F. (2023). Bivalent Vaccine against Streptococcus agalactiae and Aeromonas hydrophila in Nile Tilapia (Oreochromis niloticus): A Laboratory-Phase and Large-Scale Study. Animals, 13(21), 3338. https://doi.org/10.3390/ani13213338

Vancouver

Rivas AV, Dos Santos AGV, de Souza AB, Bueno Junior G, de Souza GF, de Souza EM, et al. Bivalent Vaccine against Streptococcus agalactiae and Aeromonas hydrophila in Nile Tilapia (Oreochromis niloticus): A Laboratory-Phase and Large-Scale Study. Animals. 2023;13(21):3338. doi:10.3390/ani13213338

BibTeX
@article{Rivas2023,
  author = {Rivas, Açucena Veleh and Dos Santos, Angelo Gabriel Vidal and de Souza, Adrieli Barboza and Bueno Junior, Gilson and de Souza, Gabriela Fernandes and de Souza, Estevam Martins and de Carvalho Nunes, Louisiane and Viana, Kelvinson Fernandes},
  title = {Bivalent Vaccine against Streptococcus agalactiae and Aeromonas hydrophila in Nile Tilapia (Oreochromis niloticus): A Laboratory-Phase and Large-Scale Study},
  journal = {Animals},
  year = {2023},
  volume = {13},
  number = {21},
  pages = {3338},
  doi = {10.3390/ani13213338}
}
Kostenlos starten →